Literature DB >> 25479089

Crystal structure of the catalase-peroxidase KatG W78F mutant from Synechococcus elongatus PCC7942 in complex with the antitubercular pro-drug isoniazid.

Saori Kamachi1, Kei Hirabayashi2, Masahiro Tamoi3, Shigeru Shigeoka3, Toshiji Tada4, Kei Wada5.   

Abstract

Isoniazid (INH) is a pro-drug that has been extensively used to treat tuberculosis. INH is activated by the heme enzyme catalase-peroxidase (KatG), but the mechanism of the activation is poorly understood, in part because the INH binding site has not been clearly established. Here, we observed that a single-residue mutation of KatG from Synechococcus elongatus PCC7942 (SeKatG), W78F, enhances INH activation. The crystal structure of INH-bound KatG-W78F revealed that INH binds to the heme pocket. The results of a thermal-shift assay implied that the flexibility of the SeKatG molecule is increased by the W78F mutation, allowing the INH molecule to easily invade the heme pocket through the access channel on the γ-edge side of the heme.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Catalase–peroxidase; Crystal structure; Isoniazid; KatG

Mesh:

Substances:

Year:  2014        PMID: 25479089     DOI: 10.1016/j.febslet.2014.11.037

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  2 in total

1.  Heterologous expression and characterization of a new heme-catalase in Bacillus subtilis 168.

Authors:  Tuyishime Philibert; Zhiming Rao; Taowei Yang; Junping Zhou; Genshu Huang; Komera Irene; Niyomukiza Samuel
Journal:  J Ind Microbiol Biotechnol       Date:  2016-03-26       Impact factor: 3.346

2.  Using cryo-EM to understand antimycobacterial resistance in the catalase-peroxidase (KatG) from Mycobacterium tuberculosis.

Authors:  Asma Munir; Michael T Wilson; Steven W Hardwick; Dimitri Y Chirgadze; Jonathan A R Worrall; Tom L Blundell; Amanda K Chaplin
Journal:  Structure       Date:  2021-01-13       Impact factor: 5.006

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.